Philippe Moreau Selected Research

Philippe Moreau Research Topics

Disease

335	Multiple Myeloma 05/2024 - 01/2002
73	Neoplasms (Cancer) 04/2024 - 01/2003
39	Disease Progression 03/2024 - 11/2005
23	Infections 01/2024 - 12/2005
19	Thrombocytopenia (Thrombopenia) 10/2023 - 04/2013
19	Neutropenia 10/2023 - 08/2009
18	Peripheral Nervous System Diseases (PNS Diseases) 02/2021 - 08/2009
17	Residual Neoplasm 03/2024 - 11/2012
12	Chromosome Aberrations (Chromosome Abnormalities) 03/2024 - 10/2010
11	Pneumonia (Pneumonitis) 10/2023 - 10/2013
9	Inflammation (Inflammations) 04/2024 - 02/2003
9	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 12/2004
8	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 01/2010
8	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2023 - 11/2005
8	Hypoxia (Hypoxemia) 08/2023 - 04/2007
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 08/2003
8	Melanoma (Melanoma, Malignant) 01/2018 - 10/2003
7	Malaria 01/2022 - 06/2013
7	Lymphopenia (Lymphocytopenia) 11/2021 - 10/2014
6	Sepsis (Septicemia) 10/2023 - 12/2009
6	Lymphoma (Lymphomas) 10/2021 - 03/2002
6	Fatigue 01/2020 - 10/2013
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 03/2002
6	Virus Diseases (Viral Diseases) 01/2017 - 01/2003
5	Vomiting 01/2023 - 03/2012
5	Immunoglobulin Light-chain Amyloidosis 10/2020 - 11/2004
5	Smoldering Multiple Myeloma 05/2020 - 10/2017
5	Choriocarcinoma 10/2019 - 11/2003
4	Septic Shock (Toxic Shock Syndrome) 10/2023 - 10/2017
4	Cytokine Release Syndrome 03/2023 - 01/2023
4	Nausea 01/2023 - 03/2012
4	Hypertension (High Blood Pressure) 10/2021 - 01/2016
4	Monoclonal Gammopathy of Undetermined Significance 01/2021 - 01/2017
4	Pain (Aches) 01/2021 - 04/2008
4	Leukemia 01/2019 - 07/2012
4	Anemia 01/2019 - 10/2016
3	Glioma (Gliomas) 01/2023 - 02/2013
3	Plasmacytoma 11/2022 - 01/2013
3	Bone Diseases (Bone Disease) 01/2022 - 03/2014
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 01/2019
3	Diarrhea 08/2020 - 03/2017
3	Febrile Neutropenia 05/2020 - 04/2013
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2019 - 09/2014

Drug/Important Bio-Agent (IBA)

151	Dexamethasone (Maxidex)FDA LinkGeneric 05/2024 - 11/2006
82	Bortezomib (Velcade)FDA Link 05/2024 - 11/2006
77	Lenalidomide (CC 5013)FDA Link 02/2024 - 05/2008
47	HLA-G Antigens (HLA G)IBA 08/2023 - 01/2003
45	carfilzomibIBA 03/2024 - 04/2014
40	Proteasome InhibitorsIBA 12/2023 - 08/2012
39	daratumumabIBA 01/2024 - 06/2016
35	pomalidomideIBA 03/2024 - 03/2013
29	Monoclonal AntibodiesIBA 03/2024 - 09/2007
28	Thalidomide (Thalomid)FDA Link 01/2023 - 01/2002
25	isatuximabIBA 03/2024 - 12/2019
22	ixazomibIBA 02/2024 - 08/2014
21	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 02/2002
20	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2005
16	Immunomodulating AgentsIBA 03/2024 - 07/2013
11	PanobinostatIBA 01/2021 - 07/2013
11	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 11/2005
9	B-Cell Maturation AntigenIBA 04/2024 - 01/2020
8	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 12/2014
8	elotuzumabIBA 01/2023 - 06/2012
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2021 - 02/2015
7	selinexorIBA 05/2024 - 01/2019
7	venetoclaxIBA 11/2021 - 04/2015
6	AntibodiesIBA 12/2023 - 01/2021
6	Chimeric Antigen ReceptorsIBA 03/2023 - 12/2019
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 11/2009
6	Prednisone (Sone)FDA LinkGeneric 01/2019 - 11/2008
5	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2024 - 01/2021
5	Bispecific AntibodiesIBA 01/2024 - 01/2022
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2018
5	CytokinesIBA 01/2021 - 10/2003
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2009
4	idecabtagene vicleucelIBA 04/2024 - 01/2021
4	AntigensIBA 03/2024 - 11/2005
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 07/2014
4	Alkylating AgentsIBA 01/2023 - 02/2010
4	Immunoglobulin G (IgG)IBA 01/2022 - 09/2013
4	Histone Deacetylase InhibitorsIBA 01/2018 - 07/2013
4	3' Untranslated Regions (3' UTR)IBA 01/2017 - 06/2013
4	Messenger RNA (mRNA)IBA 09/2016 - 10/2005
3	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 08/2023 - 09/2008
3	dabrafenibIBA 01/2023 - 07/2020
3	trametinibIBA 01/2023 - 07/2020
3	VaccinesIBA 01/2023 - 12/2021
3	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2015

Therapy/Procedure

141	Therapeutics 05/2024 - 01/2002
61	Stem Cell Transplantation 01/2023 - 02/2002
24	Transplantation 12/2023 - 05/2008
22	Drug Therapy (Chemotherapy) 12/2021 - 09/2002
9	Hematopoietic Stem Cell Transplantation 05/2022 - 12/2004
6	Immunotherapy 03/2024 - 09/2016
5	Autologous Transplantation 01/2014 - 11/2008
4	Subcutaneous Injections 11/2022 - 12/2008
4	Intravenous Administration 10/2022 - 12/2008
3	Salvage Therapy 01/2023 - 12/2004
3	Cell Transplantation 01/2020 - 02/2015